1. Home
  2. AXIL vs COCH Comparison

AXIL vs COCH Comparison

Compare AXIL & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AXIL Brands Inc.

AXIL

AXIL Brands Inc.

N/A

Current Price

$6.95

Market Cap

49.2M

ML Signal

N/A

Logo Envoy Medical Inc.

COCH

Envoy Medical Inc.

HOLD

Current Price

$0.71

Market Cap

47.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXIL
COCH
Founded
2015
1995
Country
United States
United States
Employees
N/A
47
Industry
Package Goods/Cosmetics
Blank Checks
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
49.2M
47.1M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
AXIL
COCH
Price
$6.95
$0.71
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
11.1K
172.9K
Earning Date
04-08-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.15
N/A
Revenue
$26,257,522.00
N/A
Revenue This Year
N/A
$1.58
Revenue Next Year
N/A
N/A
P/E Ratio
$46.61
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.28
$0.36
52 Week High
$10.25
$1.91

Technical Indicators

Market Signals
Indicator
AXIL
COCH
Relative Strength Index (RSI) 52.67 52.62
Support Level $6.75 $0.64
Resistance Level $6.97 $0.73
Average True Range (ATR) 0.20 0.05
MACD -0.03 0.00
Stochastic Oscillator 26.67 71.87

Price Performance

Historical Comparison
AXIL
COCH

About AXIL AXIL Brands Inc.

AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.

Share on Social Networks: